Global Sepsis Diagnostics Market

Sepsis Diagnostics Market Size, Share, Growth Analysis, By Technology(Blood Culture Technology and Immunoassays), By Application(Hospitals and Diagnostics Centres) - Industry Forecast 2024-2031


Report ID: SQMIG35A2237 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 59 | Figures: 75

Sepsis Diagnostics Market Insights

Global Sepsis Diagnostics Market size was valued at USD 0.67 billion in 2022 and is poised to grow from USD 0.74 billion in 2023 to USD 1.55 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031). 

the global market for sepsis diagnostic solutions is anticipated to expand rapidly in the next years, Due to a number of factors, including the high frequency rising awareness of sepsis, and the introduction of technologically sophisticated diagnostic solutions. According to data published by the World Health Organization (WHO), sepsis affects over 30 million people and causes 6 million deaths every year globally, with 3 million newborns and 1.2 million children being affected annually. The high prevalence of sepsis is expected to increase the demand for diagnostic solutions, which will drive the growth of the sepsis diagnostic market. The existing diagnostic tests for sepsis take up to 72 hours to provide final results, making the demand for rapid diagnostic tests high for early diagnosis of sepsis. In February 2019, researchers at the University of Strathclyde developed a ground-breaking and cost-effective test for earlier diagnosis of sepsis, which uses a microelectrode to analyze the patient's blood and provides final results in just two and a half minutes. Hospital-acquired infections (HAIs) can trigger sepsis, especially in the geriatric population, newborn babies, and people suffering from chronic diseases. According to the WHO, in developed countries, 7 out of every 100 hospitalized patients are likely to develop HAIs, whereas this number increases to 10 in developing countries due to poor healthcare infrastructure. Additionally, the Centers for Disease Control and Prevention (CDC) estimates that around 1.7 million patients suffer from HAIs every year, with around 99,000 patients dying due to HAIs in the US.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Sepsis Diagnostics Market size was valued at USD 0.67 billion in 2022 and is poised to grow from USD 0.74 billion in 2023 to USD 1.55 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031). 

The sepsis diagnostic market is highly competitive, with several established players competing for market share. These companies are investing heavily in R&D activities to develop technologically advanced diagnostic solutions and gain a competitive edge. Moreover, strategic partnerships and collaborations with other companies and healthcare facilities are commonly observed in the market. Additionally, companies are focusing on expanding their geographic presence through acquisitions, partnerships, and collaborations. Furthermore, product launches, regulatory approvals, and patent filings are among the key strategies adopted by companies to strengthen their market position. 'Abbott Laboratories (US)', 'Becton, Dickinson and Company (US)', 'bioMérieux SA (France)', 'Cepheid (US)', 'F. Hoffmann-La Roche AG (Switzerland)', 'Hologic Inc. (US)', 'Imbio LLC (US)', 'Luminex Corporation (US)', 'MedMira Inc. (Canada)', 'Meridian Bioscience, Inc. (US)', 'Nanosphere (US)', 'QIAGEN N.V. (Netherlands)', 'Thermo Fisher Scientific Inc. (US)', 'T2 Biosystems, Inc. (US)', 'Biomarck Pharmaceuticals Ltd. (UK)', 'Magnitude Biosciences (US)', 'Axis-Shield Diagnostics Ltd. (UK)', 'Biocartis Group NV (Belgium)', 'Inflammatix Inc. (US)', 'OpGen, Inc. (US)'

One of the key market trends in the sepsis diagnostic market is the increasing adoption of point-of-care (POC) testing. POC tests are designed to provide rapid and accurate diagnosis of sepsis, which can significantly improve patient outcomes. POC tests are portable, easy-to-use, and can be conducted outside the traditional laboratory setting, making them ideal for use in emergency rooms, ambulances, and critical care units. The demand for POC tests is expected to increase over the forecast period, driven by the need for rapid diagnosis and the growing adoption of digital health technologies.

North America dominated the sepsis diagnostic market due to the increasing incidence of sepsis and hospital-acquired infections, coupled with the presence of leading market players and advanced healthcare infrastructure. The US and Canada are the major contributors to the growth of the market in this region. In addition, the increasing awareness about sepsis and the availability of advanced diagnostic solutions are also driving the growth of the market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Sepsis Diagnostics Market

Product ID: SQMIG35A2237

$5,300
BUY NOW GET FREE SAMPLE